Published : Aug-2021
No. of Pages : 45
1 Neuroendocrine Tumors: Executive Summary
1.1 Related Reports
1.2 Upcoming Reports
2 Epidemiology
2.1 Disease Background
2.2 Risk Factors and Comorbidities
2.3 Global and Historical Trends
2.4 8MM Forecast Methodology
2.4.1 Sources
2.4.2 Forecast Assumptions and Methods: Population - 8MM
2.4.3 Forecast Assumptions and Methods: Diagnosed Incident Cases of NETs - 8MM
2.4.4 Forecast Assumptions and Methods: Diagnosed Incident Cases of NETs by Type
2.4.5 Forecast Assumptions and Methods: Diagnosed Incident Cases of NETs by Stage and Type
2.4.6 Forecast Assumptions and Methods: Diagnosed Incident Cases of NETs by Grade and Differentiation
2.4.7 Forecast Assumptions and Methods: Five-Year Diagnosed Prevalent Cases of NETs
2.5 Epidemiological Forecast for NETs, 2020-2030
2.5.1 Diagnosed Incident Cases of NETs
2.5.2 Age-Specific Diagnosed Incident Cases of NETs
2.5.3 Sex-Specific Diagnosed Incident Cases of NETs
2.5.4 Diagnosed Incident Cases of NETs by Type
2.5.5 Diagnosed Incident Cases of NETs by Type and Stage at Diagnosis
2.5.6 Diagnosed Incident Cases of NETs by Grade and Differentiation
2.5.7 Five-Year Diagnosed Prevalent Cases of NETs
2.6 Discussion
2.6.1 Epidemiological Forecast Insight
2.6.2 COVID-19 Impact
2.6.3 Limitations of the Analysis
2.6.4 Strengths of the Analysis
3 Appendix
3.1 Bibliography
3.2 About the Authors
3.2.1 Epidemiologist
3.2.2 Reviewers
3.2.3 Global Director of Therapy Analysis and Epidemiology
3.2.4 Global Head and EVP of Healthcare Operations and Strategy
Contact Us
List of Tables
Table 1: Risk Factors and Comorbidities for NETs
List of Figures
Figure 1: 8MM, Diagnosed Incident Cases of NETs, Both Sexes, N, All Ages, 2020 and 2030
Figure 2: 8MM, Diagnosed Incidence of NETs, Men, Cases per 100,000 Population, All Ages, 2010 and 2020
Figure 3: 8MM, Diagnosed Incidence of NETs, Women, Cases per 100,000 Population, All Ages, 2010 and 2020
Figure 4: 8MM, Sources Used and Not Used to Forecast the Diagnosed Incident Cases of NETs
Figure 5: 8MM, Sources Used to Forecast the Diagnosed Incident Cases of NETs by Type
Figure 6: 8MM, Sources Used to Forecast the Diagnosed Incident Cases of NETs by Stage at Diagnosis, by Type
Figure 7: 8MM, Sources Used to Forecast the Diagnosed Incident Cases of NETs by Grade and Differentiation, by Type
Figure 8: 8MM, Sources Used to Forecast the Five-Year Diagnosed Prevalent Cases of NETs
Figure 9: 8MM, Diagnosed Incident Cases of NETs, N, Both Sexes, All Ages, 2020
Figure 10: 8MM, Diagnosed Incident Cases of NETs by Age, N, Both Sexes, 2020
Figure 11: 8MM, Diagnosed Incident Cases of NETs by Sex, N, All Ages, 2020
Figure 12: 8MM, Diagnosed Incident Cases of NETs by Type, N, Both Sexes, 2020
Figure 13: 8MM, Diagnosed Incident Cases of NETs by Type and Stage at Diagnosis, N, Both Sexes, All Ages, 2020
Figure 14: 8MM, Diagnosed Incident Cases of NETs by Grade and Differentiation, N, Both Sexes, All Ages, 2020
Figure 15: 8MM, Five-Year Diagnosed Prevalent Cases of NETs, N, Both Sexes, All Ages, 2020
